Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Adam

Showing results (521-530 of 555) with videos related to

Pageof 56
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 10, 2019
Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipaseSoong-Hoon Kim, James A Johnson, Ji Jiang, et al.
American Journal of Medical Genetics. Part A|June 18, 2019
Perinatal distress in 1p36 deletion syndrome can mimic hypoxic ischemic encephalopathyLauren B Carter, Agatino Battaglia, Athena Cherry, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesisLalgudi S Harikrishnan, Muthoni G Kamau, Timothy F Herpin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse modelAnna Axelsson Raja, Hiroko Wakimoto, Daniel M DeLaughter, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2019
Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921]Soong-Hoon Kim, James A Johnson, Ji Jiang, et al.
American Journal of Human Genetics|March 9, 2010
Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalitiesBlake C Ballif, Aaron Theisen, Jill A Rosenfeld, et al.
Journal of Medicinal Chemistry|January 29, 2020
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In VivoGeorge Tora, Soong-Hoon Kim, Zulan Pi, et al.
Med (New York, N.Y.)|November 14, 2023
The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human diseaseLeigh C Carmody, Michael A Gargano, Sabrina Toro, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
The Medical Action Ontology: A Tool for Annotating and Analyzing Treatments and Clinical Management of Human DiseaseLeigh C Carmody, Michael A Gargano, Sabrina Toro, et al.
Journal of Medical Genetics|May 11, 2010
Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypesDamien L Bruno, Britt-Marie Anderlid, Anna Lindstrand, et al.
Pageof 56

Showing results (521-530 of 555) with videos related to

Sort By:
Pageof 56
Bioorganic & Medicinal Chemistry Letters|June 10, 2019
Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipaseSoong-Hoon Kim, James A Johnson, Ji Jiang, et al.
American Journal of Medical Genetics. Part A|June 18, 2019
Perinatal distress in 1p36 deletion syndrome can mimic hypoxic ischemic encephalopathyLauren B Carter, Agatino Battaglia, Athena Cherry, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesisLalgudi S Harikrishnan, Muthoni G Kamau, Timothy F Herpin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse modelAnna Axelsson Raja, Hiroko Wakimoto, Daniel M DeLaughter, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2019
Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921]Soong-Hoon Kim, James A Johnson, Ji Jiang, et al.
American Journal of Human Genetics|March 9, 2010
Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalitiesBlake C Ballif, Aaron Theisen, Jill A Rosenfeld, et al.
Journal of Medicinal Chemistry|January 29, 2020
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In VivoGeorge Tora, Soong-Hoon Kim, Zulan Pi, et al.
Med (New York, N.Y.)|November 14, 2023
The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human diseaseLeigh C Carmody, Michael A Gargano, Sabrina Toro, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
The Medical Action Ontology: A Tool for Annotating and Analyzing Treatments and Clinical Management of Human DiseaseLeigh C Carmody, Michael A Gargano, Sabrina Toro, et al.
Journal of Medical Genetics|May 11, 2010
Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypesDamien L Bruno, Britt-Marie Anderlid, Anna Lindstrand, et al.
Pageof 56